Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma

2010 ◽  
Vol 46 (18) ◽  
pp. 3251-3262 ◽  
Author(s):  
Birgit Geoerger ◽  
Jean-François Brasme ◽  
Estelle Daudigeos-Dubus ◽  
Paule Opolon ◽  
Corinne Venot ◽  
...  
Keyword(s):  
Growth Factor ◽  
Insulin Like Growth Factor ◽  
Receptor Antibody ◽  
Anti Tumour Activity ◽  
Tumour Activity

scholarly journals Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-xL

Oncogene ◽  
2010 ◽  
Vol 29 (48) ◽  
pp. 6367-6377 ◽  
Author(s):  
L H Mayeenuddin ◽  
Y Yu ◽  
Z Kang ◽  
L J Helman ◽  
L Cao
Keyword(s):  
Cell Death ◽  
Growth Factor ◽  
Insulin Like Growth Factor ◽  
Receptor Antibody ◽  
Rhabdomyosarcoma Cell

scholarly journals Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors

2006 ◽  
Vol 12 (20) ◽  
pp. 6153-6160 ◽  
Author(s):  
Jennifer D. Wu ◽  
Kathy Haugk ◽  
Ilsa Coleman ◽  
Lillie Woodke ◽  
Robert Vessella ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Growth Factor ◽  
Growth Factor Receptor ◽  
Insulin Like Growth Factor ◽  
Receptor Antibody
Sign in / Sign up

Export Citation Format

Share Document